Position in VRTX
as of Mar 31, 2026
· filed Apr 29, 2026
Position Value
$121,259,276
+$3,048,830 QoQ
Shares Held
271,553
+4.1% QoQ
Ownership
0.107%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
19 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Swedbank AB holds $1,230,784,492 across 20 Biotechnology names. VRTX ranks #4 (9.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
11,586,693 | $555,813,663 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
|
992,108 | $187,558,017 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
215,590 | $166,573,457 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
271,553 | $121,259,276 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
792,187 | $44,750,643 | |
| 6 | EXEL |
Exelixis, Inc.
|
841,778 | $36,103,858 | |
| 7 | INCY |
Incyte Corp
|
362,456 | $34,114,358 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
62,215 | $20,585,076 |
All Filings in VRTX
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $121,259,276 | 271,553 | Shares | Defined | 2026-04-29 | |
| 2025-12-31 | $118,210,446 | 260,743 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $99,514,156 | 254,096 | Shares | Defined | 2025-10-15 | |
| 2025-06-30 | $113,235,283 | 254,347 | Shares | Defined | 2025-07-10 | |
| 2024-12-31 | $183,867,584 | 456,587 | Shares | Defined | 2025-01-22 | |
| 2024-09-30 | $269,054,826 | 578,513 | Shares | Defined | 2024-10-11 | |
| 2024-06-30 | $312,266,888 | 666,212 | Shares | Defined | 2024-07-11 | |
| 2023-12-31 | $270,188,794 | 664,034 | Shares | Defined | 2024-12-06 | |
| 2023-09-30 | $234,118,389 | 673,257 | Shares | Defined | 2024-12-06 | |
| 2023-06-30 | $216,571,748 | 615,418 | Shares | Defined | 2024-12-06 | |
| 2023-03-31 | $198,840,677 | 631,100 | Shares | Defined | 2024-12-06 | |
| 2022-12-31 | $184,081,655 | 637,446 | Shares | Defined | 2024-12-06 | |
| 2022-09-30 | $183,138,103 | 632,514 | Shares | Defined | 2024-12-06 | |
| 2022-06-30 | $192,152,037 | 681,898 | Shares | Defined | 2024-12-06 | |
| 2022-03-31 | $179,726,907 | 688,688 | Shares | Defined | 2024-12-06 | |
| 2021-12-31 | $145,848,656 | 664,156 | Shares | Defined | 2024-12-06 | |
| 2021-09-30 | $118,846,002 | 655,196 | Shares | Sole | 2024-12-06 | |
| 2021-06-30 | $123,354,411 | 611,786 | Shares | Defined | 2024-12-06 | |
| 2021-03-31 | $120,109,112 | 558,933 | Shares | Defined | 2024-12-06 | |
| No filing history on record for this holder in this stock. | ||||||